Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Familial Combined Hyperlipidemia

cetylpyridinium chloride anhydrous has been researched along with Familial Combined Hyperlipidemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arner, E; Arner, P; Bernard, S; Buchholz, BA; Eriksson, M; Frayn, KN; Hauner, H; Liebl, J; Possnert, G; Rydén, M; Salehpour, M; Skurk, T; Spalding, KL; Steier, P1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Familial Combined Hyperlipidemia

ArticleYear
Dynamics of human adipose lipid turnover in health and metabolic disease.
    Nature, 2011, Sep-25, Volume: 478, Issue:7367

    Topics: Adipocytes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Cell Size; Cellular Senescence; Child; Child, Preschool; Cohort Studies; DNA; Dyslipidemias; Health; Humans; Hyperlipidemia, Familial Combined; Lipid Metabolism; Lipolysis; Metabolic Diseases; Middle Aged; Nuclear Weapons; Obesity; Subcutaneous Fat; Time Factors; Triglycerides; Young Adult

2011